Feature|Articles|September 17, 2024
- Pharmaceutical Executive: September 2024
- Volume 44
- Issue 9
Pharmaceutical Executive: September 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive September 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 1 year ago
A Care Sea Changeabout 1 year ago
Jan van de Winkel: Antibody Ascensionabout 1 year ago
Biotech Performance Pivot May Be in the Offingabout 1 year ago
Delivery and Disruption: Navigating a Changing Care Terrainabout 1 year ago
Outsourcing’s Evolution in the Pharma Industryabout 1 year ago
A Risk-Reward Reset: Getting Serious About Social Mediaabout 1 year ago
Copay Adjustment Chess Match: What Will Payers Do Next?about 1 year ago
Rx Power Struggle: How Pharma can Flip the PBM ScriptNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
Bob Mauch: Strengthening the Chain
3
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
